Hazell Philip
University of Sydney and University of Newcastle, NSW, Australia.
Australas Psychiatry. 2010 Dec;18(6):556-9. doi: 10.3109/10398562.2010.498049.
The aim of this paper was to conduct a practitioner review of attention-deficit/hyperactivity disorder (ADHD) co-occurring with oppositional defiant disorder (ODD) encompassing aetiological factors, associated factors, assessment, treatment and prognosis.
ADHD and ODD have both shared and unique genetic influences. Persistence of ADHD and ODD in adolescence is linked with an increased risk of delinquent behaviour, substance dependence, anxiety, depression, and possibly bipolar disorder. The diagnostic work up for ADHD must include screening for ODD, which may be achieved through targeted questioning or the use of standard symptom checklists. Treatment requires management of the core symptoms of ADHD plus, in many cases, augmentation with other treatment to address the ODD. Mild cases may respond to behaviour management alone, or monotherapy with stimulant medication or atomoxetine. Moderate to severe cases usually require a combination of pharmacotherapy, which may include clonidine, and behaviour management. Severe or refractory cases may require the introduction of an atypical antipsychotic such as risperidone.
本文旨在对注意力缺陷多动障碍(ADHD)与对立违抗性障碍(ODD)共病进行临床综述,内容涵盖病因学因素、相关因素、评估、治疗及预后。
ADHD和ODD具有共同的及独特的遗传影响因素。ADHD和ODD在青少年期持续存在与犯罪行为、物质依赖、焦虑、抑郁以及可能的双相情感障碍风险增加有关。ADHD的诊断检查必须包括对ODD的筛查,这可以通过针对性提问或使用标准症状清单来实现。治疗需要对ADHD的核心症状进行管理,在许多情况下,还需要增加其他治疗以应对ODD。轻度病例可能仅对行为管理有反应,或对使用兴奋剂药物或托莫西汀进行单一治疗有反应。中度至重度病例通常需要药物治疗(可能包括可乐定)与行为管理相结合。严重或难治性病例可能需要引入非典型抗精神病药物如利培酮。